CORDIS
EU research results

CORDIS

English EN
Genome architecture in relation to disease

Genome architecture in relation to disease

Objective

It is now well recognised that many human diseases, including cancer and communicable diseases, involve complex (epi-) genetic processes, composed of both hereditable and environmental factors. MC-GARD is aimed at the development of the European Research Area (ERA) and proposes three conferences and two training events. This series of events (SCF) is designed to survey the development and application of techniques for the investigation of human genome from three architectural perspectives and in relation to cancer and heritable diseases. Research in this field is rapidly expanding and will have a large impact on our understanding, prognosis and diagnosis of human disease and prevention. Recent studies of cancer (i.e. glioblastoma, breast cancer), inherited complex diseases (i.e. heart defects, mental retardation) and communicable diseases (i.e. leprosy, HIV/AIDS) have demonstrated the clinical relevance of genetic variations. Additional progresses should be anticipated, with wide-scale SNP projects combined with DNA sequence analysis of large numbers of individuals.

These developments obscure the distinction between major clinical disciplines encompassing genetics, microbiology, pathology and oncology, and require cross-talk with disciplines such as genomics, epigenetics, cytology, (3-D) image analysis, bioinformatics and statistics. MC-GARD will bring together junior researchers from these diverse disciplines for interaction with leading researchers and clinicians, as well as policymakers, which will allow Europe to make a significant step forward. The societal reasons for organising the events are to further our understanding of disease susceptibility and progression, and translate new tools post-genomically into diagnostics. The conferences will also provide a venue for small to medium-size companies and encourage interdisciplinary contacts. Training events will provide early-stage researchers with hands-on experience in genomics and emerging diagnostic techniques.

Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG.UNIVERSITY MEDICAL CENTER

Address

De Boelelaan 1105
Amsterdam

Netherlands

Administrative Contact

Bauke YLSTRA (Dr)

Participants (4)

Sort alphabetically

Expand all

FUNDACIÓN CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS CARLOS III

Spain

HELSINGIN YLIOPISTO

Finland

THE UNIVERSITY OF EDINBURGH

United Kingdom

UNIVERSIDADE DO MINHO

Portugal

Project information

Grant agreement ID: 45732

  • Start date

    1 October 2006

  • End date

    30 September 2009

Funded under:

FP6-MOBILITY

Coordinated by:

VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG.UNIVERSITY MEDICAL CENTER

Netherlands